Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Gains from Sales and Divestitures: 2012-2017

Historic Gains from Sales and Divestitures for Cryo Cell International (CCEL) over the last 6 years, with FY2017 value amounting to $83238.0.

  • Cryo Cell International's Gains from Sales and Divestitures rose 4705.88% to $50550.0 in Q3 2018 from the same period last year, while for Aug 2018 it was $50550.0, marking a year-over-year increase of 4705.88%. This contributed to the annual value of $83238.0 for FY2017, which is 3195.4% down from last year.
  • Latest data reveals that Cryo Cell International reported Gains from Sales and Divestitures of $83238.0 as of FY2017, which was down 3195.4% from $122326.0 recorded in FY2016.
  • Cryo Cell International's 5-year Gains from Sales and Divestitures high stood at $145756.0 for FY2013, and its period low was $34580.0 during FY2015.
  • Moreover, its 5-year median value for Gains from Sales and Divestitures was $83238.0 (2017), whereas its average is $92261.8.
  • Its Gains from Sales and Divestitures has fluctuated over the past 5 years, first tumbled by 8095.9% in 2013, then skyrocketed by 25374.78% in 2016.
  • Over the past 5 years, Cryo Cell International's Gains from Sales and Divestitures (Annual) stood at $145756.0 in 2013, then tumbled by 48.26% to $75409.0 in 2014, then tumbled by 54.14% to $34580.0 in 2015, then soared by 253.75% to $122326.0 in 2016, then crashed by 31.95% to $83238.0 in 2017.
  • Its Gains from Sales and Divestitures was $83238.0 in FY2017, compared to $122326.0 in FY2016 and $34580.0 in FY2015.